Indoco Remedies Ltd.
NSE: INDOCO | BSE: 532612
₹209.66
As on 29-May-2026IST
Market cap
₹1,935 Cr
Revenue (TTM)
₹1,844 Cr
P/E Ratio
--
P/B Ratio
2.1
Div. Yield
0.1 %
Quality Score
1/10
Growth Score
5/10
Valuation Score
2/10
Momentum Score
5/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-95 Cr
-
ROE
-7.3 %
-
ROCE
-0.4 %
-
Industry P/E
42.06
-
EV/EBITDA
20.2
-
Debt to Equity
0.5
-
Book Value
₹101.8
-
EPS
₹-10
-
Face value
2
-
Shares outstanding
92,303,605
10 Years Aggregate
CFO
₹1,263.74 Cr
EBITDA
₹1,817.81 Cr
Net Profit
₹630.52 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indoco Remedies
| -10.6 | -0.8 | 3.6 | -14.6 | -14.4 | -11.9 | -3.2 |
|
BSE Healthcare
| 7.8 | 5.0 | 6.6 | 10.1 | 25.8 | 13.9 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Indoco Remedies
| -29.4 | -14.9 | -2.8 | -10.5 | 49.3 | 61.3 | -12.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indoco Remedies
|
209.7 | 1,935.2 | 1,843.5 | -98.7 | 0.8 | -9.6 | -- | 2.1 |
| 1,055.5 | 12,968.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 23 | 3.9 | |
| 449.4 | 7,778.2 | 947.3 | 247.8 | 28.5 | 18.9 | 31.4 | 5.7 | |
| 1,051.2 | 10,972.7 | 1,054.9 | 256.3 | 27.8 | 13.7 | 42.1 | 5.8 | |
| 1,696.0 | 32,050.6 | 9,203.5 | 941.3 | 15.4 | 19.6 | 34.7 | 6.5 | |
| 404.3 | 4,403.3 | 165.8 | 46.7 | 37.8 | 16.9 | 94.3 | 15.3 | |
| 17,088.0 | 21,897.9 | 2,023.0 | 364.0 | 23.9 | 20.8 | 60.2 | 11.7 | |
| 792.5 | 4,009.9 | 811.3 | 21.0 | 0.7 | 2.1 | 195.2 | 3.1 | |
| 1,120.7 | 5,148.6 | 649.5 | 121.6 | 23.7 | 13.2 | 44.6 | 5.5 | |
| 279.3 | 7,367.0 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsAbout Indoco Remedies
Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient,... ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom synthesis of molecules and intermediates, process chemistry research and development, non-infringing process designing and scale up, and analytical method development/validation solutions, as well as contract manufacturing services. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India. Read more
-
Incorporated
1947
-
Chairman
Suresh G Kare
-
Managing Director
Aditi Panandikar
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Indoco Remedies Ltd.’s IPO? Explore our IPO Details page.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsAnnouncement under Regulation 30 (LODR)-Demise
15-May-2026No News & Announcements are available.
FAQs for Indoco Remedies
What is the current share price of Indoco Remedies Ltd Today?
The share price of Indoco Remedies Ltd is ₹209.66 (NSE) and ₹209.65 (BSE) as of 29-May-2026 IST. Indoco Remedies Ltd has given a return of -14.45% in the last 3 years.
What is the current PB & PE ratio of Indoco Remedies Ltd?
Since, TTM earnings of Indoco Remedies Ltd is negative, P/E ratio is not available.
The P/B ratio of Indoco Remedies Ltd is 2.06 times as on 29-May-2026, a 8 discount to its peers’ median range of 2.25 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
2.12
|
|
2024
|
30.76
|
2.74
|
|
2023
|
21.09
|
2.92
|
|
2022
|
22.42
|
3.84
|
|
2021
|
28.57
|
3.46
|
What is the 52 Week High and Low of Indoco Remedies Ltd?
The 52-week high and low of Indoco Remedies Ltd are Rs 349.80 and Rs 162.19 as of 30-May-2026.
What is the market cap of Indoco Remedies Ltd?
Indoco Remedies Ltd has a market capitalisation of ₹ 1,935 Cr as on 29-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Indoco Remedies Ltd?
Before investing in Indoco Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
